News & Events

Publications

Health Affairs Forefront
Are We Valuing Prescription Drugs Appropriately?
Health Policy Open
Variation in Medicaid and commercial coverage of cell and gene therapies
Journal of Alzheimer's Disease
Life-Sustaining Treatments Among Medicare Beneficiaries with and without Dementia at the End of Life
Health Affairs Forefront
The Case For Including Dynamic Drug Pricing In Cost-Effectiveness Analyses Under The IRA
The American Journal of Managed Care
Varied Use of Step Therapy Among Medicare Advantage Plans
The Milbank Quarterly
Improving Food and Drug Administration–Centers for Medicare and Medicaid Services Coordination for Drugs Granted Accelerated Approval
Cost Effectiveness and Resource Allocation
Assessing the impact of grief on quality of life, work productivity, and health outcomes for parents bereaved from SMA: A study protocol
The New England Journal of Medicine
Turning CMS into a health technology assessment organization
JAMA Network Open
Follow-On Indications for Orphan Drugs Related to the Inflation Reduction Act